A Review Of The Components Of The iShares Biotech ETF: Gilead Sciences
An attractive trading opportunity is before us with GILD serving as the potential catalyst. A strong earnings report next Monday with a decisive close above the 50 week MA may lead to a change in sentiment in this battered sector...
Read More